18 and older, any sex, with Stroke or Exercise. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Ratio of Average Activity Duration (RAAD)Primary· During device use in an inpatient setting (about 1 to 3 weeks of use).
The RAAD assesses the amount of measured arm activity during cued exercise epochs compared to non-cued epochs. A RAAD value greater than 1.0 indicates that the amount of arm activity in response to Souvenir cues exceeded the amount of activity during non-cued periods of time.
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
1.223
± 0.63
System Usability ScalePrimary· Two time points: After device use in an inpatient setting (after about 1 to 3 weeks of use); after device use in home settings (after 2 days of use).
The System Usability Scale (SUS) assesses the usability of the activity cueing system and monitoring system within the context of encouraging therapeutic arm activity. Scores are provided on a scale ranging from 1 to 100, with higher scores indicating greater perceived usability. Scores greater than 68 are generally considered to indicate "passable" usability.
SUS obtained after using the device in an inpatient setting
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
80.1
± 13.8
SUS obtained after using the device in home settings
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
83.3
± 15.2
Intrinsic Motivation Inventory (IMI)Primary· After device use in an inpatient setting (after about 1 to 3 weeks of use).
The IMI assesses subjective experience of motivation in response to the system's vibrotactile cues. IMI comprises 37 questions, with answers provided on a Likert scale (1-7).
IMI questions span 6 psychosocial dimensions:
* interest/enjoyment; higher scores = more interest/enjoyment with cued activities
* effort/importance; higher scores = more perceived importance and more effort put into performing cued activities
* value/usefulness higher scores = more perceived value and usefulness of cued activities
* perceived choice; higher scores = greater degree to which participants felt that they h
interest/enjoyment dimension
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
4.9
± 1.3
effort/importance dimension
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
5.4
± 1.4
value/usefulness dimension
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
6.2
± 0.9
perceived choice dimension
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
6.0
± 0.9
perceived competence dimension
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
5.8
± 1.2
pressure/tension dimension
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
2.8
± 1.0
Quebec User Evaluation of Satisfaction With Technology (QUEST)Primary· Two time points: After device use in an inpatient setting (after about 1 to 3 weeks of use); after device use in home settings (after 2 days of use).
The QUEST assesses user satisfaction with the system and its delivery by the research team.. The QUEST comprises 12 questions, with answers provided on a Likert scale (1-5). For each question, a score of "1" = not at all satisfied where "5" is "very satisfied". A composite score (min = 1; max = 5) is computed for the QUEST by averaging across all questions. A score of 3 separates (+) from (-) experiences.
QUEST post-device use in an inpatient setting
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
4.52
± 0.46
QUEST after use in home settings
Group
Value
95% CI
Survivors of Stroke in Early Stages of Recovery
4.5
± 0.5
Sponsor's own description
This project evaluates the feasibility of using custom wearable technology and associated procedures to increase activity of the more-involved upper extremity during the earliest stages of recovery from stroke by increasing the amount of therapeutic exercise during idle-time. The proposed research is relevant to public health because it takes steps to mitigate a significant problem in physical rehabilitation using low-cost technology to motivate and monitor idle-time exercise without adding significantly to clinician workloads. The project aligns with the NICHD / NCMRR Research Plan on Rehabilitation by exploiting a mobile health (mHealth) and sensor-based approach to promote health and wellness through participant-engaged, data-driven, individualized care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
· recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment
· NA
· recruiting
NCT07356011 — Exoskeleton for Balance
· NA
· recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in
· NA
· recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients
· NA
· recruiting
Other Marquette University trials
Trials by the same sponsor.
NCT07372183 — Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers
· not yet recruiting
NCT06624982 — Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation
· recruiting
NCT06858293 — Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feasibility Study
· NA
· recruiting
NCT06734052 — Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees With Chronic Knee Symptoms
· NA
· completed
NCT06340893 — Exercise Training in Children With Communication Impairments
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marquette University
Last refreshed: 16 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05900999.